Smiths Medical - Smiths Group plc


The cookie settings on this website are set to ‘allow all cookies’. Leaving your settings to ‘allow all cookies’ means you consent to a website remembering your preferences and generally enhancing the user experience. If you prefer a website to not remember your preferences, you can change your settings at any time by changing the privacy settings of your browser.

Find out more about cookies >

General enquiries

Smiths Medical
6000 Nathan Lane N.
Plymouth, Minnesota 55442

T: +1 763 383 3000
F: +1 763 383 3679

Where we operate

We have operations in over 30 countries with manufacturing located in the US, UK, Mexico, Italy, Germany, Czech Republic, and China. We sell to approximately 120 markets and, while the US continues to be our largest single market with over 50% of sales, we continue to build our presence in developing markets.

View map

Smiths Medical is a leading supplier of specialty medical devices and consumables that are vital to patient care around the world. Smiths Medical is dedicated to providing innovative solutions and superior support to help healthcare professionals and providers ensure safety, enhance patient outcomes and improve the total cost of care.

Our broad portfolio offers products that aid in the delivery of medication, protect healthcare workers and patients from cross-infection and injury, manage patient airway and temperature, as well as deliver specialised care in areas of invitro fertilisation, diagnostics and emergency patient transport.

Key facts

Employees 7,600

2016 Headline revenue £874m

2016 Operating profit margin 21.4%

Revenue by sector

Infusion systems: 31%

Medication delivery systems (eg ambulatory infusion and syringe pumps) that relieve pain and treat patients with acute and chronic conditions

Vascular access: 33%

Safety-enabled devices (eg catheters, needles) protect healthcare workers and patients from needlestick injuries and cross-infection

Vital care: 28%

Products reduce hospital acquired infections, alleviate breathing difficulties and maintain body temperature

Specialty products: 8%

Specialised care in areas such as IVF, diagnostics and emergency patient transport

Competitive strengths

  • Strong market positions in chosen clinical areas
  • Highly recognised and respected brands
  • Reputation for quality and safety
  • Extensive global sales network
  • Innovative pipeline of new products in development

Financial highlights

Revenue performance £m

Revenue by sector £874m

  1. Infusion systems 31%
  2. Vascular access 33%
  3. Vital care 28%
  4. Specialty products 8%

Growth drivers

  • Ageing populations with increasing life expectancy and quality of life expectations
  • Growing incidence of chronic diseases
  • Increasing need for interoperable and connected systems
  • Growth of alternate site and home-based medical care
  • Rising healthcare spend in developing markets, offsetting budget constraints in developed markets

Principal operating regions

We have operations in over 30 countries, with manufacturing located in North America, Europe and Asia.


Around three-quarters of our end users are hospitals. The remainder comprise alternate care and OEM partners.

Priorities for 2017

  • Lay the foundation for accelerated growth and continued margin expansion
  • Build engagement, excitement and loyalty with customers and colleagues
  • Expand our portfolio of products and services
  • Improve marketing and sales force excellence
  • Drive operational excellence

Useful links


back to top

Smiths Group divisions:

John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, Flex-Tek

Smiths Group plc:
Registered office 4th Floor, 11-12 St James’s Square, London, SW1Y 4LB
Incorporated in England No. 137013
Copyright 2017 Smiths Group plc.
All rights Reserved | Legal Notice | Privacy Policy | Cookie Policy